openPR Logo
Press release

Diabetes Devices Market Accelerated by CGM Adoption and Smart Insulin Tech Innovations | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE

06-28-2025 11:44 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Diabetes Devices Market

Diabetes Devices Market

The Diabetes Devices market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment opportunities, product development strategies, or expansion into high-growth regions, this report serves as your essential guide to navigating today's dynamic market environment.

Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/diabetes-devices-market?ophp

Diabetes Devices Market Growth

Diabetes Devices Market reached US$ 33.4 billion in 2024 and is expected to reach US$ 64.8 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
In 2022, the Diabetes Devices Market was at US$ 29.39 Billion, and by 2023, it had

Comprehensive Insight into Diabetes Devices Market Landscape and Growth Trends:

Diabetes Devices include glucose monitors, insulin pumps, and CGMs that help manage blood sugar levels. The market is expanding rapidly due to the growing global diabetes burden, alongside tech-driven innovations in remote patient monitoring and wearable health tools.

Major Players Shaping the Competitive Landscape:

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Insulet Corporation, Nipro Corporation, Johnson & Johnson Services, Inc., Senseonics, Inc., Tandem Diabetes Care, Inc. and among others.

Important Mergers, Acquisitions, and Market Shifts:

✅ Cardinal Health announced in late 2024 (closing early 2025) the acquisition of Advanced Diabetes Supply Group (ADSG) for approximately $1.1 billion.

✅ In April 2025, Dexcom received FDA clearance for its upgraded G7 15‐Day continuous glucose monitor, offering extended sensor life (up to 15.5 days) and enhanced convenience. Dexcom's stock rose over 8% on the news

✅ Medtronic obtained FDA approval in November 2024 for its InPen app to support the upcoming Smart MDI system, integrating the app, InPen smart insulin pen, and Simplera CGM-bringing AI insights and dose corrections to patients on multiple daily injections

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/diabetes-devices-market?ophp

Methodology and Scope:

This Diabetes Devices Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Diabetes Devices Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Diabetes Devices market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Diabetes Devices industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Diabetes Devices market?

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=diabetes-devices-market?ophp

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Devices Market Accelerated by CGM Adoption and Smart Insulin Tech Innovations | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE here

News-ID: 4085803 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Endoscopy Devices Market Surges with AI Integration and Outpatient Procedure Growth | Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Cook Medical
Endoscopy Devices Market Surges with AI Integration and Outpatient Procedure Gro …
The Endoscopy Devices market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring
Incontinence Devices Market Rises with Aging Population and Home Healthcare Solutions | B. Braun Melsungen AG, ConvaTec Inc., Coloplast Corp, BD, Promedon GmbH, Medtronic Plc
Incontinence Devices Market Rises with Aging Population and Home Healthcare Solu …
The Incontinence Devices market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring
Companion Diagnostics Market Expansion Backed by Targeted Cancer Therapy Developments | Key Players: Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc.
Companion Diagnostics Market Expansion Backed by Targeted Cancer Therapy Develop …
The Companion Diagnostics market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring
Hydrocolloids Market Grows with Rising Clean Label Food Trends and Functional Ingredients | 3M, Amparo medical Technologies., Scapa, Sarasota Medical Products
Hydrocolloids Market Grows with Rising Clean Label Food Trends and Functional In …
The Hydrocolloids market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment

All 5 Releases


More Releases for Diabetes

Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025. Research and Development Pursuits to Introduce Novel Products Stokes Growth The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food